Browsing: PSMA

Top Line: Can PSMA PET help identify patients being worked up for prostate cancer who could avoid biopsy? The Study:…

Top Line: Can PSMA-PET kinetics complement PSA surveillance following prostate ultra-hypofractionation?The Study: A prospective phase 2 trial uniquely performed serial…

PSMA PET has fundamentally changed the way we stage prostate cancer. However, staging systems and risk stratification schemes are slow…

At ASTRO 2025, results from the LUNAR trial showed that adding 177Lu-PNT2002 to SBRT for oligometastatic prostate cancer more than…

Several trials have evaluated the impact of PSMA-PET on salvage radiation for prostate cancer. In this randomized phase 2 trial…

Top Line: Who wouldn’t love standardized PSMA-PET reads to ease clinically applicability?The Study: PSMA-PET imaging is an amazing tool offering…

This multicenter retrospective analysis of 406 men with prostate cancer undergoing PSMA-PET attempted to quantify the so-called “tumor sink effect,”…

A randomized phase 2 trial demonstrates larger tumor volume as measured on PSMA-PET is both prognostic of worse survival and…

Top Line: Lutetium-177 is the radioisotope used in Pluvicto for metastatic prostate cancer primarily decays by beta emission. Terbium-161 is…

What happens to PSMA uptake on PET CT following definitive radiation? We’re conditioned to think about PET scans showing metabolic…